Diagnostic Accuracy of Ultrasonography in Axillary Staging in Breast Cancer Patients
- PMID: 38264585
- PMCID: PMC10802873
- DOI: 10.4103/jmu.jmu_99_22
Diagnostic Accuracy of Ultrasonography in Axillary Staging in Breast Cancer Patients
Abstract
Background: Breast cancer is the most common malignancy affecting women all over the world and represents 7% of all cancer-related deaths in the UK. One of the most crucial elements in assessing a patient's prognosis and chance of survival with breast cancer is the condition of their axillary lymph nodes. Ultrasonography (US) is now used as a routine preoperative diagnostic tool for pretherapeutic axillary evaluation. The aim of the current study is to investigate the diagnostic accuracy of US in axillary staging in breast cancer patients.
Methods: We carried out this retrospective study for all invasive breast cancer patients who had surgery in addition to preoperative axillary staging using US during the period from January 2020 to February 2021. The final histology results were compared with the preoperative US findings to ascertain the sensitivity, specificity, positive predictive value, and negative predictive value of AUS in axillary staging.
Results: One hundred and twenty-eight patients were included in our study. The average age of diagnosis was 63.9 ± 12.3 years of age. We calculated sensitivity rate of 59.6%, specificity rate of 95.1%, positive predictive value of 87.5%, and negative predictive value of 80.2% with overall diagnostic accuracy of 82.2%.
Conclusion: Despite the important role of preoperative US in axillary staging in breast cancer patients; it failed to detect metastatic diseases in 14.8% of our patients. These findings necessitate the routine histological evaluation of the axilla for more accurate staging of the disease.
Keywords: Axilla; breast cancer; diagnostic accuracy; histology; ultrasonography.
Copyright: © 2023 Journal of Medical Ultrasound.
Conflict of interest statement
There are no conflicts of interest.
Figures




Similar articles
-
Evaluating the preoperative breast cancer characteristics affecting the accuracy of axillary ultrasound staging.Breast J. 2020 Feb;26(2):162-167. doi: 10.1111/tbj.13635. Epub 2019 Sep 27. Breast J. 2020. PMID: 31562691
-
Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer.BMC Cancer. 2008 Jun 9;8:165. doi: 10.1186/1471-2407-8-165. BMC Cancer. 2008. PMID: 18541009 Free PMC article.
-
Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma.Cancer. 2002 Sep 1;95(5):982-8. doi: 10.1002/cncr.10786. Cancer. 2002. PMID: 12209680 Clinical Trial.
-
FDG-PET for axillary lymph node staging in primary breast cancer.Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:S97-102. doi: 10.1007/s00259-004-1531-z. Epub 2004 May 5. Eur J Nucl Med Mol Imaging. 2004. PMID: 15133635 Review.
-
Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.J Surg Oncol. 2004 Mar;85(3):102-11. doi: 10.1002/jso.20022. J Surg Oncol. 2004. PMID: 14991881 Review.
Cited by
-
Can negative axillary ultrasound reliably predict pathologically negative axillary lymph node status in breast cancer patients with cT ≤3 cm, cN0, and HER2-positive?-a retrospective, single-institution study.Gland Surg. 2024 Aug 31;13(8):1511-1521. doi: 10.21037/gs-24-140. Epub 2024 Aug 28. Gland Surg. 2024. PMID: 39282035 Free PMC article.
References
-
- Ghoncheh M, Pournamdar Z, Salehiniya H. Incidence and mortality and epidemiology of breast cancer in the world. Asian Pac J Cancer Prev. 2016;17:43–6. - PubMed
-
- [[Last accessed on 2022 Mar 25]]. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/s... .
-
- Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: Update of a randomised controlled study. Lancet Oncol. 2006;7:983–90. - PubMed
-
- Warmuth MA, Bowen G, Prosnitz LR, Chu L, Broadwater G, Peterson B, et al. Complications of axillary lymph node dissection for carcinoma of the breast: A report based on a patient survey. Cancer. 1998;83:1362–8. - PubMed
-
- Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: Overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927–33. - PMC - PubMed
LinkOut - more resources
Full Text Sources